Lianbio
LIANY
$0.20
$0.0052.56%
OTC PK
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 17.28M | 15.59M | 15.14M | 20.88M | 16.29M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 26.30M | 25.04M | 25.97M | 29.25M | 24.55M |
Operating Income | -26.30M | -25.04M | -25.97M | -29.25M | -24.55M |
Income Before Tax | -23.45M | -21.42M | -23.61M | -18.63M | -21.89M |
Income Tax Expenses | 586.00K | 200.00K | 438.00K | -350.00K | 6.00K |
Earnings from Continuing Operations | -24.04M | -21.62M | -24.05M | -18.28M | -21.90M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -24.04M | -21.62M | -24.05M | -18.28M | -21.90M |
EBIT | -26.30M | -25.04M | -25.97M | -29.25M | -24.55M |
EBITDA | -25.98M | -24.71M | -25.65M | -28.93M | -24.27M |
EPS Basic | -0.22 | -0.20 | -0.22 | -0.17 | -0.20 |
Normalized Basic EPS | -0.14 | -0.12 | -0.14 | -0.11 | -0.13 |
EPS Diluted | -0.22 | -0.20 | -0.22 | -0.17 | -0.20 |
Normalized Diluted EPS | -0.14 | -0.12 | -0.14 | -0.11 | -0.13 |
Average Basic Shares Outstanding | 107.17M | 107.16M | 107.16M | 108.13M | 108.35M |
Average Diluted Shares Outstanding | 107.17M | 107.16M | 107.16M | 108.13M | 108.35M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |